Oncimmune Holdings PLC operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Oncimmune Holdings PLC with three other
pharmaceutical manufacturers in Europe:
Enorama Pharma AB
sales of 2.15 million Swedish Kronor [US$250,459.66 ]
(842,000.00 Euros [US$980,205.88 ]
of which 69%
was Product sales (own and third party)), and
(£347,937.00 [US$479,912.98 ]
Sales were up sharply during the second
quarter of 2021 versus the previous year's second quarter.
During the second
quarter of 2021, sales at Oncimmune Holdings PLC totalled
an increase of 493.2%
from the £308,000.00 in sales at the company during the second quarter of 2020.
Sales increased substantially in 2020:
Oncimmune Holdings PLC reported sales of £509,000.00 (US$702.07 thousand)
May of 2020.
increase of 197.7%
versus 2019, when the company's sales were £171,000.00 .